Short-term Mortality Prediction by the SOFA Score in Acute Decompensated Heart Failure

Completed

• Conditions: Acute Decompensated Heart Failure

• Registration Number: NCT06354426
• Lead Sponsor: Hanoi Heart Hospital

Brief Summary

Data on the use of sequential organ failure assessment (SOFA) in patients with cardiovascular disease are increasing. Several studies demonstrated that the SOFA score can identify short-term mortality in patients with acute decompensated heart failure (ADHF). This study was conducted to determine the prognostic value of the admission SOFA score in patients hospitalised for ADHF and to assess its ability in predicting the 30-day readmission rate.

Detailed Description

Not available

Study Timeline

• Study Start: 2022-07-01
• Primary Completion: 2023-08-31
• Study Completion: 2023-08-31
• Study First Submitted: 2024-03-30
• Status Verified: 2024-04
• Study First Submitted QC: 2024-04-05
• Last Update Submitted: 2024-04-05
• Study First Posted: 2024-04-09
• Last Update Posted: 2024-04-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 216

Inclusion Criteria

• All patients over 18 years old who were hospitalised for acute heart failure were included (either new-onset acute heart failure or ADHF).

Exclusion Criteria

• Patients with septic shock or pulmonary infarction were excluded.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mortality	Within 30 days from the day of hospitalization	The sequential organ failure assessment (SOFA) score was used to assess the relation to the all cause mortality of the patient with acute decompensated heart failure. Higher SOFA score is correlated with higher in-hospital mortality rate and 30-day mortality regardless of age, gender, or other comorbidities.

Secondary Outcome Measures

Name	Time	Method
Re-admission rate	Within 30 days	To assess the prediction ability of the sequential organ failure assessment (SOFA) score in regard of re-admission rate.

Trial Locations

Locations (1)

Hanoi Heart Hospital; 🇻🇳 Hanoi, Hoan Kiem, Vietnam